Congress trades in IBRX
Members of Congress have reported 2 trades in IBRX (ImmunityBio, Inc. - Common Stock) under the STOCK Act: 2 purchases and 0 sales by 1 member. The latest was reported Oct 12, 2026, 12 days after the trade.
By member
| Member | Trades | Bought · sold | Latest |
|---|---|---|---|
 Lisa McClainR-MI · House | 2 | 2 · 0 | Oct 12 |
Every trade reported
| Traded | Member | Trade | Amount | Days to report |
|---|---|---|---|---|
| Sep 30 reported Oct 12 |
Lisa McClainR-MI · House | Buy | $1K–$15K | 12 days |
| Sep 28 reported Oct 12 |
Lisa McClainR-MI · House | Buy | $1K–$15K | 14 days |
Questions
Which members of Congress trade IBRX?
Lisa McClain (2), from the reports on record.
Is Congress buying or selling IBRX?
In the last 90 days: 2 purchases worth $2K–$30K and 0 sales worth —, in the dollar ranges members report.
Can I get an alert when a member of Congress trades IBRX?
Yes, free. Follow IBRX in the InsiderBeacon app and every Congress trade in it reaches you minutes after the report is posted, along with insider buys and sales in the stock.
Data as of Oct 12, 2026, from the periodic transaction reports members file under the STOCK Act, read from the House Clerk's and the Senate's disclosure sites. Members report up to 45 days after a trade, in dollar ranges, so totals here are ranges too, and no returns are worked out from them. Not investment advice. Disclaimer